v3.26.3
SUBSEQUENT EVENTS (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Nov. 05, 2026
USD ($)
Oct. 02, 2026
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Oct. 01, 2026
Oct. 18, 2024
USD ($)
Subsequent Event [Line Items]                
Paydown of Deflecto Facility         $ 1,763 $ 12,100    
Subsequent Event                
Subsequent Event [Line Items]                
Paydown of Deflecto Facility $ 17,000              
Subsequent Event | Mycovia Pharmaceuticals, Inc.                
Subsequent Event [Line Items]                
Voting rights acquired             100.00%  
Note Purchase Agreement | Senior Notes | Subsequent Event | Benchmark Energy II DevCo, LLC                
Subsequent Event [Line Items]                
Debt instrument, face amount   $ 47,500            
Amount committed   27,500            
Accordion amount   20,000            
Amount issued   18,500            
Discount   $ 550            
Discount factor, percentage   2.00%            
Borrowing capacity remaining   $ 9,000            
Cash equity contribution   $ 6,000            
Deflecto Credit Agreement | Line of Credit                
Subsequent Event [Line Items]                
Debt instrument, face amount               $ 55,000
Paydown of Deflecto Facility     $ 0 $ 10,900 $ 1,800 $ 12,100    
Deflecto Credit Agreement | Line of Credit | Subsequent Event                
Subsequent Event [Line Items]                
Liquidity minimum 10,000              
Minimum EBITDA $ (500)              
Period One | Deflecto Credit Agreement | Line of Credit                
Subsequent Event [Line Items]                
Debt to EBITDA ratio               3.75
Period Two | Deflecto Credit Agreement | Line of Credit                
Subsequent Event [Line Items]                
Debt to EBITDA ratio               3.25
Period Three | Deflecto Credit Agreement | Line of Credit                
Subsequent Event [Line Items]                
Debt to EBITDA ratio               2.75